NASDAQ:IMRX - Nasdaq - US45254E1073 - Common Stock - Currency: USD
TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 320.00K | 2.08M | 2.31M | |||
Cost Of Goods | N/A | 0.00 | 160.00K | 1.15M | 1.28M | |||
Gross Profit | N/A | 0.00 | 160.00K | 930.00K | 1.03M | |||
Operating Expenses | 60.47M | 58.41M | 51.90M | 34.82M | 18.11M | |||
Research and Development | 43.63M | 41.40M | 36.11M | 26.51M | 14.98M | |||
Selling, General, and Administrative Expenses | 16.62M | 16.76M | 15.61M | 8.27M | 3.11M | |||
Operating Income | -60.47M | -58.41M | -51.74M | -33.89M | -17.08M | |||
Interest Income/Expense | 3.25M | 3.61M | 1.01M | 170.00K | 40.00K | |||
Other Income/Expense | 1.17M | 1.33M | 220.00K | -130.00K | N/A | |||
Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
Income Before Taxes | -56.07M | -53.47M | -50.51M | -33.84M | -17.04M | |||
Income Tax | N/A | N/A | N/A | -310.00K | N/A | |||
Net Income | -56.07M | -53.47M | -50.51M | -33.54M | -17.04M | |||
EBITDA | -60.08M | -58.06M | -51.46M | -33.84M | -17.06M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -1.91 | -1.88 | -1.91 | -2.46 | -0.70 | |||
Non GAAP EPS | -1.91 | -1.89 | -1.92 | N/A | N/A | |||
Statistics | ||||||||
Gross Profit Margin | N/A | N/A | 50.00% | 44.71% | 44.59% | |||
Profit Margin | N/A | N/A | -15784.38% | -1612.50% | -737.66% | |||
Operating Profit Margin | N/A | N/A | -16168.75% | -1629.33% | -739.39% |
All data in USD